{"data":[{"accessionNo":"0001193125-26-086369","issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","personName":"Timothy Williams","relationship":"SVP & General Counsel","securityClass":"Common Stock","broker":"Merrill Lynch","unitsToSell":42434,"aggregateMarketValue":350755,"unitsOutstanding":59108030,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001193125-26-086325","issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","personName":"Joakim Wijkstrom","relationship":"SVP, Chief Marketing Officer","securityClass":"Common Stock","broker":"Merrill Lynch","unitsToSell":30800,"aggregateMarketValue":254589,"unitsOutstanding":59108030,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001193125-26-086321","issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","personName":"Mihael H. Polymeropoulos","relationship":"Officer, Chairman of the Board","securityClass":"Common Stock","broker":"Merrill Lynch","unitsToSell":156235,"aggregateMarketValue":1276976,"unitsOutstanding":59108030,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001193125-26-086301","issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","personName":"Kevin Moran","relationship":"SVP, CFO & Treasurer","securityClass":"Common Stock","broker":"Merrill Lynch","unitsToSell":42442,"aggregateMarketValue":350821,"unitsOutstanding":59108030,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001193125-26-086349","issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","personName":"Gunther Birznieks","relationship":"SVP, Business Development","securityClass":"Common Stock","broker":"Merrill Lynch","unitsToSell":42431,"aggregateMarketValue":350730,"unitsOutstanding":59108030,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001193125-26-064742","issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","personName":"Honore Tage","relationship":"Director","securityClass":"Common Stock","broker":"Merrill Lynch","unitsToSell":30000,"aggregateMarketValue":240900,"unitsOutstanding":59108030,"approxSaleDate":"2026-02-23","exchange":"NASDAQ","filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"}],"updatedAt":"2026-10-24T13:54:07.596Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/vnda","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}